The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Dihexa 1401708 83 5 Dihexa: A Comprehensive Guide to This Promising Peptide Designing Ruthenium Phthalocyanine with Chiral Pockets Formed by (1R,2S,5R) Menthoxy Groups for Enantioselective Catalysis ACS Catalysis